phorbol 12,13-dibutyrate has been researched along with Lymphoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heinz, R; Kreiner, G; Kundi, M; Marosi, C; Nowotny, H; Onderka, E; Pirc-Danoewinata, H; Porenta, G; Schlögl, E | 1 |
| Hatake, K; Hayasawa, H; Horiuchi, T; Ikeda, K; Ikeda, M; Inoue, R; Ishizaka, Y; Itoh, T; Matsumoto, M; Mishima, Y; Mori, M; Niho, Y; Ozawa, K; Terui, Y; Tomizuka, H; Ueda, M; Uwai, M; Yamada, M | 1 |
| Gross, JL; Horuk, R | 1 |
| DeFranco, AL; Page, DM | 1 |
| Abraham, I; Burnett, BA; Groppi, VE; Leach, KL; Mayo, JK; Powers, EA | 1 |
| Holsapple, MP; Kramer, CM; Sando, JJ | 1 |
6 other study(ies) available for phorbol 12,13-dibutyrate and Lymphoma
| Article | Year |
|---|---|
Phorbol-12,13-dibutyrate improves the quality of cytogenetic preparation in lymphoid malignancies.
Topics: Calcimycin; Chromosome Aberrations; Cytogenetics; Female; Humans; Indicators and Reagents; Lymphoma; Male; Metaphase; Phorbol 12,13-Dibutyrate | 1995 |
A new apoptotic pathway for the complement factor B-derived fragment Bb.
Topics: Antibodies, Monoclonal; Apoptosis; Blotting, Western; Complement C3; Complement C3 Convertase, Alternative Pathway; Complement C3b; Dose-Response Relationship, Drug; Fas Ligand Protein; fas Receptor; Gene Expression; HL-60 Cells; Humans; Integrin alphaXbeta2; Leukemia; Lymphoma; Membrane Glycoproteins; Peptide Fragments; Phorbol 12,13-Dibutyrate; Receptors, Complement; Receptors, Tumor Necrosis Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2000 |
Protein kinase C-linked inactivation of the interleukin-1 receptor in a human transformed B-cell line.
Topics: B-Lymphocytes; Caenorhabditis elegans Proteins; Carrier Proteins; Cell Line; Cell Membrane; Enzyme Activation; Humans; Interleukin-1; Kinetics; Lymphoma; Phorbol 12,13-Dibutyrate; Phorbols; Protein Kinase C; Receptors, Drug; Receptors, Immunologic; Receptors, Interleukin-1; Recombinant Proteins; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1990 |
Role of phosphoinositide-derived second messengers in mediating anti-IgM-induced growth arrest of WEHI-231 B lymphoma cells.
Topics: Animals; Antibodies, Anti-Idiotypic; B-Lymphocytes; Calcium; Cell Line; Dose-Response Relationship, Immunologic; Ethers; Growth Inhibitors; Immunoglobulin M; Ionomycin; Kinetics; Leukocyte Count; Lipopolysaccharides; Lymphocyte Activation; Lymphoma; Mice; Phorbol 12,13-Dibutyrate; Phorbol Esters; Phosphatidylinositols | 1988 |
Phorbol myristate acetate inhibits growth in S49 cells: isolation of resistant variants.
Topics: Animals; Cell Division; Drug Resistance; Electrophoresis, Polyacrylamide Gel; Lymphoma; Mice; Molecular Weight; Ornithine Decarboxylase; Phorbol 12,13-Dibutyrate; Phorbol Esters; Protein Kinase C; RNA, Messenger; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1987 |
Lack of direct effect of 2,3,7,8-tetrachlorodibenzo-P-dioxin (TCDD) on protein kinase C activity in EL4 cells.
Topics: Cell Line; Dioxins; Interleukin-2; Lymphoma; Phorbol 12,13-Dibutyrate; Phorbol Esters; Polychlorinated Dibenzodioxins; Protein Kinase C | 1986 |